A phase II evaluation of fazarabine in high-grade gliomas: a Southwest Oncology Group study

Fine HA, Dear KBG, Loeffler JS, Black PM, Canellos GP (1991) Meta-analysis of radiotherapy with and without adjuvant chemotherapy for malignant gliomas in adults. Proc Am Soc Clin Oncol 10: 125 Glazer RI, Knode MC (1984) 1-B-d-arabinosyl-5-azacytosine: cytocidal activity and effects on the synthesis and methylation of DNA in human colon carcinoma cells. Mol Pharmacol 26: 381–387 Heideman R, Balis F, Lester C, et al (1987) Preclinical pharmacology of arabinosyl-5-azacytidine (AAC). Proc Am Assoc Cancer Res 28: 4 Shapiro WR (1986) Therapy of adult malignant brain tumors: what have clinical trials taught us? Semin Oncol 13: 38–45 Townsend A, Leclerc JM, Dutschman G, et al (1985) Metabolism of 1-B-d-arabinofuranosyl-5-azacytosine and incorporation into DNA of human T-lymphoblastic cells (Molt-4). Cancer Res 45: 3522–3528 Walker MD, Alexander E, Hunt WE, et al (1976) Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas: a cooperative clinical trial. J Neurosurg 49: 333–343